AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Definitive Healthcare Corp.
Video analysis: DH
All videosNo video analysis for this stock yet. Request one from our team.
News: DH
Financial Review: HealthStream (NASDAQ:HSTM) versus Definitive Healthcare (NASDAQ:DH)
HealthStream (NASDAQ: HSTM - Get Free Report) and Definitive Healthcare (NASDAQ: DH - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk. Earnings and Valuation This table compares HealthStream and
Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International
FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- The special committee (the “Special Committee”) of the Board of Directors of Definitive Healthcare Corp. (the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it has received a non-binding indication of interest (the “Proposal”), dated as of September 1, 2026, from Advent International, L.P., on behalf of certain of its managed funds (collectively, “Advent”), to acquire all of the outstanding shares of the Company's Class A common stock (the “Class A Common Stock”) and all of the outstanding limited liability company interests of AIDH TopCo, LLC (the “Definitive OpCo Units”), in each case, that are not already owned by Advent or Jason Krantz, the Company's founder and Executive Chairman, for an all-cash purchase price of $1.02 per share of Class A common stock, and an equivalent amount per Definitive OpCo Unit.
Definitive Healthcare Appoints Clay Ritchey as CEO
FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Board of Directors has appointed Clay Ritchey as the Company's next Chief Executive Officer and as a member of the Board of Directors, each effective September 8, 2026.
Definitive Healthcare (NASDAQ:DH) & Certara (NASDAQ:CERT) Financial Comparison
Definitive Healthcare (NASDAQ: DH - Get Free Report) and Certara (NASDAQ: CERT - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, institutional ownership and valuation. Insider and Institutional Ownership 98.7% of Definitive Healthcare
Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of “Reduce” by Analysts
Definitive Healthcare Corp. (NASDAQ: DH - Get Free Report) has received a consensus rating of "Reduce" from the nine analysts that are covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and one has assigned a strong buy recommendation to the company.
Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript
Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript
Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.07 per share a year ago.
Definitive Healthcare Q2 Earnings Call Highlights
Definitive Healthcare NASDAQ: DH reported second-quarter fiscal 2026 revenue and profitability that met or exceeded its guidance ranges, while management pointed to improving retention trends and continued investments in artificial intelligence products as key components of its plan to return to growth.
